Signal
Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down more than 50% des...
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-03-26 14:37 UTCUpdated 2026-03-26 17:15 UTC
rss
equitiesfierce_biotech
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.2 top sources shown
limited source diversity in top sources
Overview
Wave's stock wavers on obesity drug data Phil.Taylor Thu, 26/03/2026 - 17:15.
Score total
0.99
Momentum 24h
2
Posts
2
Origins
2
Source types
1
Duplicate ratio
0%
All evidence
All evidence
Wave's stock wavers on obesity drug data
pharmaphorum · pharmaphorum.com · 2026-03-26 17:15 UTC
Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down more than 50% despite the biotech hai...
Fierce Biotech · fiercebiotech.com · 2026-03-26 14:37 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- pharmaphorum (1)
- Fierce Biotech (1)
Top origin domains (this list)
- pharmaphorum.com (1)
- fiercebiotech.com (1)